Response to trametinib of two pediatric myeloid malignancies cases harboring RAS mutation and monosomy 7

Juanjuan Lia Department of Hematology, Affiliated Children’s Hospital of Capital Institute of Pediatrics, Beijing, China

https://orcid.org/0000-0002-7098-3095

Junhui Lia Department of Hematology, Affiliated Children’s Hospital of Capital Institute of Pediatrics, Beijing, China

Tao Hua Department of Hematology, Affiliated Children’s Hospital of Capital Institute of Pediatrics, Beijing, China

Xiaodai Cuib Experiment Cencer, Capital Institute of Pediatrics, Beijing, China

Zeliang Songa Department of Hematology, Affiliated Children’s Hospital of Capital Institute of Pediatrics, Beijing, China

Xiaodong Shia Department of Hematology, Affiliated Children’s Hospital of Capital Institute of Pediatrics, Beijing, ChinaCorrespondence[email protected]

Rong Liua Department of Hematology, Affiliated Children’s Hospital of Capital Institute of Pediatrics, Beijing, ChinaCorrespondence[email protected]

show all

Click to increase image sizeClick to decrease image size

Acknowledgements

We sincerely thank the patients and their family members who contributed to the study.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Response to trametinib of two pediatric myeloid malignancies cases harboring RAS mutation and monosomy 7

Information for

Open access

Opportunities

Help and information

Response to trametinib of two pediatric myeloid malignancies cases harboring RAS mutation and monosomy 7

Acknowledgements

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature